Detalhe da pesquisa
1.
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study.
Ann Oncol
; 35(1): 77-90, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37879444
2.
SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment.
Ann Oncol
; 33(1): 109-111, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34687893
3.
Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.
Ann Oncol
; 27(4): 693-9, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26802155
4.
Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer.
Br J Cancer
; 113(3): 484-91, 2015 Jul 28.
Artigo
Inglês
| MEDLINE | ID: mdl-26180921
5.
Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors.
Br J Cancer
; 111(12): 2268-74, 2014 Dec 09.
Artigo
Inglês
| MEDLINE | ID: mdl-25349975
6.
The FEN1 E359K germline mutation disrupts the FEN1-WRN interaction and FEN1 GEN activity, causing aneuploidy-associated cancers.
Oncogene
; 34(7): 902-11, 2015 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-24608430